Depletion of circRNA circ_CDK14 inhibits osteosarcoma progression by regulating the miR-520a-3p/GAB1 axis

Peng-Fei Wu1, Xiao-Ming Tang1, Hai-Lang Sun1

  • 1Department of Orthopedics, The Affiliated Huai'an NO.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.

Neoplasma
|August 5, 2021
PubMed

Insights

Circular RNA cyclin dependent kinase 14 (circ_CDK14) promotes osteosarcoma (OS) growth by sponging miR-520a-3p and upregulating GAB1. Inhibiting circ_CDK14 suppressed OS progression and tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteosarcoma (OS) is a deadly bone cancer.
  • Circular RNAs (circRNAs) are emerging as key regulators in OS development.
  • The specific mechanisms of circ_CDK14 in OS remain largely unclear.

Purpose of the Study:

  • To elucidate the functional role and molecular mechanism of circ_CDK14 in osteosarcoma.
  • To investigate the interaction between circ_CDK14, miR-520a-3p, and GAB1 in OS progression.

Main Methods:

  • Quantitative real-time PCR and western blot assays for gene and protein expression.
  • Cellular assays including MTT, colony formation, flow cytometry, and Transwell assays.
  • Dual-luciferase reporter assay and xenograft assay to confirm interactions and in vivo effects.

Main Results:

  • Circ_CDK14 and GAB1 were upregulated, while miR-520a-3p was downregulated in OS tissues and cells.
  • Circ_CDK14 depletion inhibited OS cell proliferation, migration, invasion, and tumorigenesis, while promoting apoptosis.
  • Circ_CDK14 acts as a sponge for miR-520a-3p, which targets GAB1, thereby regulating OS progression.

Conclusions:

  • Circ_CDK14 promotes osteosarcoma development by regulating the miR-520a-3p/GAB1 axis.
  • Circ_CDK14 knockdown significantly inhibits OS tumor growth in vivo.
  • Circ_CDK14 is a potential therapeutic target for osteosarcoma.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K